Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.
Related to this article
The FDA has approved pembrolizumab plus enfortumab vedotin in MIBC.
In a recent OncLive Peer Exchange, expert investigators discussed the utility of ctDNA and MRD testing in solid tumors.
Advertisement
Advertisement
Trending on OncLive
1
Dr Ravi on Barriers to PSMA-PET in mHSPC
2
Zanubrutinib Extends TTNT, OS vs Acalabrutinib in Real-World R/R MCL
3
FDA Approves Pegfilgrastim Biosimilar for Non-Myeloid Malignancies
4
GE HealthCare and Mayo Clinic Aim to Advance Personalized Cancer Treatment Through New Theranostics Research Collaboration
5